Tissue | Expression Dynamics | Abbreviation |
Esophagus | | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Skin | | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00158331 | Colorectum | SER | peptide transport | 58/2897 | 264/18723 | 3.08e-03 | 2.70e-02 | 58 |
GO:00301001 | Colorectum | SER | regulation of endocytosis | 48/2897 | 211/18723 | 3.29e-03 | 2.82e-02 | 48 |
GO:0060996 | Colorectum | SER | dendritic spine development | 26/2897 | 99/18723 | 3.83e-03 | 3.17e-02 | 26 |
GO:00900871 | Colorectum | SER | regulation of peptide transport | 46/2897 | 202/18723 | 3.86e-03 | 3.18e-02 | 46 |
GO:00027911 | Colorectum | SER | regulation of peptide secretion | 45/2897 | 200/18723 | 5.35e-03 | 4.03e-02 | 45 |
GO:00510471 | Colorectum | SER | positive regulation of secretion | 65/2897 | 310/18723 | 5.71e-03 | 4.19e-02 | 65 |
GO:00902761 | Colorectum | SER | regulation of peptide hormone secretion | 44/2897 | 196/18723 | 6.08e-03 | 4.42e-02 | 44 |
GO:00508081 | Colorectum | SER | synapse organization | 85/2897 | 426/18723 | 7.17e-03 | 4.99e-02 | 85 |
GO:00226042 | Colorectum | MSS | regulation of cell morphogenesis | 103/3467 | 309/18723 | 2.70e-10 | 2.56e-08 | 103 |
GO:00161972 | Colorectum | MSS | endosomal transport | 79/3467 | 230/18723 | 7.04e-09 | 4.39e-07 | 79 |
GO:00725831 | Colorectum | MSS | clathrin-dependent endocytosis | 22/3467 | 47/18723 | 8.74e-06 | 2.16e-04 | 22 |
GO:00301002 | Colorectum | MSS | regulation of endocytosis | 63/3467 | 211/18723 | 4.05e-05 | 7.66e-04 | 63 |
GO:00160492 | Colorectum | MSS | cell growth | 123/3467 | 482/18723 | 7.15e-05 | 1.21e-03 | 123 |
GO:00068981 | Colorectum | MSS | receptor-mediated endocytosis | 69/3467 | 244/18723 | 1.18e-04 | 1.82e-03 | 69 |
GO:00510561 | Colorectum | MSS | regulation of small GTPase mediated signal transduction | 82/3467 | 302/18723 | 1.31e-04 | 1.99e-03 | 82 |
GO:00015582 | Colorectum | MSS | regulation of cell growth | 105/3467 | 414/18723 | 2.97e-04 | 3.90e-03 | 105 |
GO:00458071 | Colorectum | MSS | positive regulation of endocytosis | 33/3467 | 100/18723 | 3.73e-04 | 4.72e-03 | 33 |
GO:00158332 | Colorectum | MSS | peptide transport | 71/3467 | 264/18723 | 4.79e-04 | 5.60e-03 | 71 |
GO:19035321 | Colorectum | MSS | positive regulation of secretion by cell | 74/3467 | 282/18723 | 7.93e-04 | 8.36e-03 | 74 |
GO:00510472 | Colorectum | MSS | positive regulation of secretion | 80/3467 | 310/18723 | 8.55e-04 | 8.75e-03 | 80 |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
TSN | CD8TCM | Colorectum | AD | CHI3L2,SPARCL1,TIPRL, etc. | 7.32e-02 | |
TSN | MAST | Colorectum | ADJ | CHI3L2,SPARCL1,TIPRL, etc. | 9.13e-02 | |
TSN | CD8TCM | Colorectum | ADJ | CHI3L2,SPARCL1,TIPRL, etc. | 3.24e-02 | |
TSN | CD8TCM | Colorectum | FAP | CHI3L2,SPARCL1,TIPRL, etc. | 5.36e-02 | |
TSN | GC | Colorectum | MSI-H | CHI3L2,SPARCL1,TIPRL, etc. | 7.18e-02 | |
TSN | GC | Colorectum | SER | CHI3L2,SPARCL1,TIPRL, etc. | 3.22e-02 | |
TSN | DIFF | Esophagus | Healthy | MSMO1,NMU,RHEB, etc. | 1.12e-01 | |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TSN | insertion | In_Frame_Ins | novel | c.453_453+1insTCTTTATTA | p.Ser152_Arg153insLeuLeuSer | p.S152_R153insLLS | Q15631 | protein_coding | | | TCGA-A8-A09T-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD |
TSN | SNV | Missense_Mutation | | c.464C>A | p.Ser155Tyr | p.S155Y | Q15631 | protein_coding | deleterious(0) | probably_damaging(0.928) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TSN | SNV | Missense_Mutation | | c.475N>A | p.Val159Met | p.V159M | Q15631 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CA-6716-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | oxaliplatin | CR |
TSN | SNV | Missense_Mutation | | c.268N>T | p.His90Tyr | p.H90Y | Q15631 | protein_coding | deleterious(0.01) | possibly_damaging(0.895) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TSN | SNV | Missense_Mutation | novel | c.586N>A | p.Asp196Asn | p.D196N | Q15631 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
TSN | SNV | Missense_Mutation | novel | c.634N>A | p.Leu212Ile | p.L212I | Q15631 | protein_coding | tolerated(0.22) | possibly_damaging(0.748) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
TSN | SNV | Missense_Mutation | novel | c.362N>G | p.Glu121Gly | p.E121G | Q15631 | protein_coding | deleterious(0.03) | possibly_damaging(0.664) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
TSN | SNV | Missense_Mutation | | c.622N>T | p.Val208Leu | p.V208L | Q15631 | protein_coding | deleterious(0) | probably_damaging(0.953) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
TSN | SNV | Missense_Mutation | rs774578869 | c.524A>G | p.Asn175Ser | p.N175S | Q15631 | protein_coding | tolerated(0.67) | benign(0.027) | TCGA-B5-A0JZ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | PD |
TSN | SNV | Missense_Mutation | | c.34N>A | p.Gly12Ser | p.G12S | Q15631 | protein_coding | tolerated(0.75) | benign(0.003) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |